Latest Headlines

1. Spectrum Solutions Receives IRB Approval For Saliva-Based Multi-Omic Discovery, Detection And Diagnostic Innovation 5/25/2022

   Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation.

2. Roche Develops Unique PCR Tests To Detect The Monkeypox Virus 5/25/2022

   Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus kits in response to recent monkeypox virus concerns.

3. CENTOGENE’s CentoCloud® Is Now CE-Marked As One Of The Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework 5/25/2022

   Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that its cloud-based Software as a Service (SaaS) platform for the identification, prioritization, and classification of human genetic variants is now CE-marked under the In Vitro Diagnostics Directive (98/79/EC).

4. Premier Medical Laboratory Services And Palmetto Infusion Announce Partnership, Streamlining Medical Diagnostics And Infusion Services For The Southeast 5/24/2022

   Premier Medical Laboratory Services (PMLS), one of the largest medical diagnostic laboratories in the nation, and Palmetto Infusion, the leading provider for infusion and injection treatments for chronic and acute illnesses, have joined forces to provide unmatched quality and convenience in medical diagnostics and infusion services.

5. Sysmex Inostics Expands Blood Test Offerings For Detection Of Acute Myeloid Leukemia 5/24/2022

   Sysmex Inostics, a global leader in the liquid biopsy revolution, has expanded its offering of CLIA-validated tests to include AML-SEQ™, a focused panel to detect mutations of the three most prevalent genes found in Acute Myeloid Leukemia (AML) – IDH1/2 & NPM1.

6. OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent For Scanning, Indexing And Analyzing Of The Tissue Area At The Same Time 5/24/2022

   OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office.

7. Indica Labs Achieves CE-IVD Certification For AI-Based Prostate Cancer Detection And Gleason Grading Tool 5/23/2022

   Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies.

8. LumiraDx Receives WHO Emergency Use Listing For SARS-CoV-2 Ag Test 5/20/2022

   LumiraDx Limited a next-generation point of care diagnostics company, announced today that its rapid COVID-19 antigen assay, LumiraDx SARS-CoV-2 Ag Test has successfully received the Emergency Use Listing (EUL) by the World Health Organization (WHO) in their latest response effort to combat COVID-19.

9. Imperial Partners With Laboratory In DR Congo For Rapid Polio Detection 5/19/2022

   Late detection of poliovirus transmission is one of the greatest risks to polio eradication. Imperial developed a method for rapid detection of polio.

10. Leica Biosystems New Advanced Staining Solution Transcends Expectations With Speed, Quality And Diagnostic Productivity 5/19/2022

    Leica Biosystems is launching BOND-PRIME, a premium Advanced Staining solution, to advance diagnostic productivity in the lab.